Why Bausch Health Companies Is Plunging Today

·2 min read
Why Bausch Health Companies Is Plunging Today

Investors of healthcare giant Bausch Health Companies (NYSE: BHC) are having a rather rainy afternoon. During the quarter, Bausch Health improved its revenue by 26% year over year to $2.1 billion. In addition, Bausch Health is spinning off its dermatology laser hardware Solta Medical subsidiary into an independent publicly traded company.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting